Home > News > Disease diagnosis, drug development focus of UH prof's biochip research
September 1st, 2004
Disease diagnosis, drug development focus of UH prof's biochip research
Abstract:
Leading the way to disease diagnosis and drug development, biochip research at the University of Houston will be presented to an international audience of top nanoscientists next week. B. Montgomery Pettitt, the Hugh Roy and Lillie Cranz Cullen Distinguished Professor of Chemistry at the University of Houston, has been selected as one of the plenary speakers at the Pacific Rim Nanoscience Conference Sept. 7-11 in Broome, Western Australia. Pettitt is one of only three American scientists among the 21 invited speakers.
Source:
medicalnewstoday
Bookmark:
| Related News Press |
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||